NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea · Delayed Price · Currency is KRW 2,590.00
+85.00 (3.39%)
Sep 1, 2026, 3:30 PM KST
NeoImmuneTech Market Cap
NeoImmuneTech has a market cap or net worth of 256.07 billion as of September 1, 2026. Its market cap has decreased by -49.56% in one year.
Market Cap
256.07B
Enterprise Value
220.07B
Revenue
1.76B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,590.00
ChartMarket Cap Chart
Since March 16, 2021, NeoImmuneTech's market cap has decreased from 7.32T to 256.07B, a decrease of -96.50%. That is a compound annual growth rate of -45.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 256.07B | -36.91% |
| Dec 30, 2025 | 405.85B | -27.02% |
| Dec 30, 2024 | 556.13B | -44.44% |
| Dec 28, 2023 | 1.00T | -49.29% |
| Dec 29, 2022 | 1.97T | -61.23% |
| Dec 30, 2021 | 5.09T | -30.48% |
| Mar 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC Corp. | 460.37B |
| Proteina | 396.16B |
| SillaJen | 360.24B |
| MEDIPOST | 350.99B |
| Genomictree | 288.19B |
| Bioneer | 214.48B |
| GC Cell | 202.72B |
| HLB Therapeutics | 196.24B |